Novel lung adenocarcinoma and nuclear factor-kappa B (NF-κB) inhibitors: Synthesis and evaluation of lantadene congeners

European Journal of Medicinal Chemistry

Volumn 74, Issue , 2014, Pages 135-144

  Suthar, Sharad Kumar ^a   Boon, Hong L ^b   Sharma, Manu ^a  

^a JAYPEE UNIVERSITY OF INFORMATION TECHNOLOGY   (India)

^b Drug Discovery Laboratory   (Malaysia)

Author keywords

A549 lung cancer cells; Inhibitor of nuclear factor kappa B kinase ; Lantadene congeners; Nuclear factor kappa B; Tumor necrosis factor alpha

Indexed keywords

22BETA HYDROXYOLEANOLIC ACID; ANTINEOPLASTIC AGENT; CISPLATIN; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LANTADENE A; LANTADENE B; TRITERPENOID; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CHEMICAL STRUCTURE; CONFORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYDROLYSIS; IN VITRO STUDY; LANTANA CAMARA; LUNG ADENOCARCINOMA; PH; PLANT LEAF; SIGNAL TRANSDUCTION;

A549 LUNG CANCER CELLS; INHIBITOR OF NUCLEAR FACTOR-KAPPA B KINASE Β; LANTADENE CONGENERS; NUCLEAR FACTOR-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

ADENOCARCINOMA; CELL LINE, TUMOR; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE SPECTROSCOPY; NF-KAPPA B; OLEANOLIC ACID; PHOSPHORYLATION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84892768306     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2013.12.052     Document Type: Article

References (17)

1. W. Xiao Advances in NF-kappaB signaling transduction and transcription Cell. Mol. Immunol. 1 2004 425 435
2. E. Pikarsky, R.M. Porat, I. Stein, R. Abramovitch, S. Amit, S. Kasem, E. Gutkovich-Pyest, S. Urieli-Shoval, E. Galun, and Y. Ben-Neriah NF-κB functions as a tumour promoter in inflammation-associated cancer Nature 431 2004 461 466 (Pubitemid 39329586)
3. D.S. Basseres, and A.S. Baldwin Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression Oncogene 25 2006 6817 6830 (Pubitemid 44657854)
4. M. Karin Nuclear factor-kappaB in cancer development and progression Nature 441 2006 431 436 (Pubitemid 44050137)
5. F. Li, and G. Sethi Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy Biochim. Biophys. Acta 1805 2010 167 180
6. B.K. Bednarski, X. Ding, K. Coombe, A.S. Baldwin, and H.J. Kim Active roles for inhibitory kappaB kinases alpha and beta in nuclear factor-kappaB-mediated chemoresistance to doxorubicin Mol. Cancer Ther. 7 2008 1827 1835
7. S.C. Gupta, C. Sundaram, S. Reuter, and B.B. Aggarwal Inhibiting NF-κB activation by small molecules as a therapeutic strategy Biochim. Biophys. Acta 1799 2010 775 787
8. J. Kaur, M. Sharma, P.D. Sharma, and M.P. Bansal Chemopreventive activity of lantadenes on two-stage carcinogenesis model in Swiss albino mice: AP-1 (c-jun), NF kB (p65) and p55 expression by ELISA and immunohistochemical localization Mol. Cell. Biochem. 314 2008 1 8
9. J. Kaur, M. Sharma, P.D. Sharma, and M.P. Bansal Antitumor activity of lantadenes in DMBA/TPA induced skin tumors in mice: expression of transcription factors Am. J. Biomed. Sci. 2 2010 79 90
10. M. Sharma, P.D. Sharma, M.P. Bansal, and J. Singh Lantadene A-induced apoptosis in human leukemia HL-60 cells Ind. J. Pharmacol. 39 2007 140 144 (Pubitemid 47094667)
11. M. Sharma, P.D. Sharma, and M.P. Bansal Lantadenes and their esters as potential antitumor agents J. Nat. Prod. 71 2008 1222 1227
12. N.K. Tailor, H.B. Lee, and M. Sharma Synthesis and in vitro anticancer studies of novel C-2 arylidene congeners of lantadenes Eur. J. Med. Chem. 64 2013 285 291
13. N.K. Tailor, V. Jaiswal, S.S. Lan, H.B. Lee, and M. Sharma Synthesis, selective cancer cytotoxicity and mechanistic studies of novel analogs of lantadenes Anticancer Agents Med. Chem. 13 2013 957 966
14. J.A. Schmid, and A. Birbach IkappaB kinase beta (IKKbeta/IKK2/IKBKB) - a key molecule in signaling to the transcription factor NF-kappaB Cytokine Growth Factor Rev. 19 2008 157 165 (Pubitemid 351382281)
15. S. Ballaz, and J.L. Mulshine The potential contributions of chronic inflammation to lung carcinogenesis Clin. Lung Cancer 5 2003 46 62 (Pubitemid 36974741)
16. G. Xu, Y.C. Lo, Q. Li, G. Napolitano, X. Wu, X. Jiang, M. Dreano, M. Karin, and H. Wu Crystal structure of inhibitor of κB kinase β Nature 472 2011 325 330
17. S.K. Suthar, N. Tailor, H.B. Lee, and M. Sharma Reduced lantadenes A and B: semi-synthetic synthesis, selective cytotoxicity, apoptosis induction and inhibition of NO, TNF-α production in HL-60 cells Med. Chem. Res. 22 2013 3379 3388